Unilink Bioscience Private Limited
About Unilink Bioscience Private Limited
Data last updated:
Unilink Bioscience Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 16 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U24239PN2021PTC204342.
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Asma Imran Patel and Imran Ahmad Moin Ahmad Kazi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Pune, Maharashtra.
As per the financials filed for FY 2025, the company reported a revenue of ₹21.99 Lakh, a growth of 23% compared to the previous year. For the same year it recorded a net profit of ₹22,224 (net margin 1%) and EBITDA of ₹55,955 (EBITDA margin 2.5%).
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressSr. No. 23/1A/2/1B/5/26/2A/2B Fortune Siddhipriy, Autadwadi Handewadi, Pune, Maharashtra, India – 412308
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Unilink Bioscience Private Limited
The main business activity of Unilink Bioscience is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Unilink Bioscience Private Limited FY 2025 filings available
Unilink Bioscience Private Limited reported revenue of ₹21.99 Lakh (up 23% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Unilink Bioscience Private Limited
Revenue rose 23% in the latest year. EBITDA rose 150% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Unilink Bioscience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• |
| EBITDA | ₹55,955 | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹22,224 | •••• | •••• | •••• |
| Balance Sheet | ||||
| Share Capital | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• |
Financial Ratios of Unilink Bioscience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 2.5% | •••• | •••• | •••• |
| Net Profit Margin | 1% | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• |
| Liquidity and Debt | ||||
| Current Ratio | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• |
| Efficiency and Growth | ||||
| Asset Turnover | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Unilink Bioscience are in the company report.
Financial statements from FY 2022
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Unilink Bioscience Private Limited
Unilink Bioscience Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Wholesale Trading). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Brightindia Processors Private Limited | ₹22.01 Lakh (FY 2020) | •••• | •••• | 3.0% | •••• | Dhar, Madhya Pradesh, India |
| Kubisi Green Earth Limited | ₹22 Lakh (FY 2024) | •••• | •••• | 359.0% | •••• | Delhi, India |
| Shreeon Pharma Private Limited | ₹22 Lakh (FY 2024) | •••• | •••• | 4.0% | •••• | Thane, Maharashtra, India |
| Ise Cards India Limited | ₹21.99 Lakh (FY 2025) | •••• | •••• | 95.0% | •••• | Uttar Pradesh, India |
| Dstar Electra India Private Limited | ₹21.99 Lakh (FY 2024) | •••• | •••• | •••• | Pune, Maharashtra, India | |
| Unilink Bioscience Private Limited this company | ₹21.99 Lakh (FY 2025) | •••• | •••• | 23.0% | •••• | Pune, Maharashtra, India |
| Casomed Pharmaceuticals Private Limited | ₹21.99 Lakh (FY 2022) | •••• | •••• | -16.0% | •••• | Chennai, Tamil Nadu, India |
| Pastiche Mobility Solutions Private Limited | ₹21.99 Lakh (FY 2024) | •••• | •••• | •••• | Panchkula, Haryana, India | |
| Sai Abasan Private Limited | ₹21.98 Lakh (FY 2024) | •••• | •••• | 12.0% | •••• | Kolkata, West Bengal, India |
| Advait Pharmasol Private Limited | ₹21.98 Lakh (FY 2024) | •••• | •••• | 8433.0% | •••• | Mumbai, Maharashtra, India |
| Laaj International Private Limited | ₹21.98 Lakh (FY 2025) | •••• | •••• | 37.0% | •••• | New Delhi, Delhi, India |
Peers are the five companies nearest above and the five nearest below Unilink Bioscience by revenue in the same principal business activity (Wholesale Trading), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Unilink Bioscience Private Limited
Unilink Bioscience has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Asma Imran Patel | Director | 16 Sep 2021 | 5 Years 0 Months | Current |
| Imran Ahmad Moin Ahmad Kazi Also directs: Lifesy Healthcare Private Limited | Director | 16 Sep 2021 | 5 Years 0 Months | Current |
Charges & Borrowings of Unilink Bioscience Private Limited
Unilink Bioscience Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Unilink Bioscience Private Limited
Employment history and EPFO contributions of people linked to Unilink Bioscience.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Unilink Bioscience Private Limited
Unilink Bioscience Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Asma Imran Patel was appointed as Director on 16 Sep 2021.
Credit Ratings, Litigation & Regulatory Alerts for Unilink Bioscience Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Unilink Bioscience Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Unilink Bioscience Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Unilink Bioscience Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Unilink Bioscience Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Unilink Bioscience Private Limited
Unilink Bioscience is an active private limited company based in Pune, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 16 September 2021 (5+ years old) and is registered under CIN U24239PN2021PTC204342.
Unilink Bioscience reported revenue of ₹21.99 Lakh for FY 2025 (up 23% YoY).
Unilink Bioscience has 2 current directors:
- Asma Imran Patel - Director
- Imran Ahmad Moin Ahmad Kazi - Director
Unilink Bioscience reported a net profit of ₹22,224 (net margin 1%) and EBITDA of ₹55,955 (EBITDA margin 2.5%) for FY 2025, as per its filed financial statements.
The CIN (Corporate Identification Number) of Unilink Bioscience is U24239PN2021PTC204342. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Unilink Bioscience was incorporated on 16 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
The peers of Unilink Bioscience by revenue are Brightindia Processors Private Limited, Kubisi Green Earth Limited, Shreeon Pharma Private Limited, Ise Cards India Limited, Dstar Electra India Private Limited and 5 more, all in the same principal business activity (Wholesale Trading).
Asma Imran Patel was appointed as Director on 16 Sep 2021. Imran Ahmad Moin Ahmad Kazi was appointed as Director on 16 Sep 2021.
The registered office of Unilink Bioscience is at Sr. No. 231A21B5262A2B Fortune Siddhipriy, Autadwadi Handewadi, Pune, Maharashtra, India – 412308.
Unilink Bioscience has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh.
Unilink Bioscience operates in the pharma industry, in the drug formulation and development segment.